Faculty Opinions recommendation of Development of a safe oral Abeta vaccine using recombinant adeno-associated virus vector for Alzheimer's disease.

George Perry

doi:10.3410/f.1022359.253715

Faculty Opinions recommendation of Development of a safe oral Abeta vaccine using recombinant adeno-associated virus vector for Alzheimer's disease. — George Perry | RDL Network

Faculty Opinions recommendation of Development of a safe oral Abeta vaccine using recombinant adeno-associated virus vector for Alzheimer's disease.

Discussion(0)

Related publications

Faculty Opinions recommendation of Autoantibodies to redox-modified oligomeric Abeta are attenuated in the plasma of Alzheimer's disease patients.

Faculty Opinions recommendation of In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses.

Faculty Opinions recommendation of Alzheimer disease beta-amyloid activity mimics cholesterol oxidase.

Faculty Opinions recommendation of Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis.

Faculty Opinions recommendation of Antibody capture of soluble Abeta does not reduce cortical Abeta amyloidosis in the PDAPP mouse.